Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: the Chief who wrote (1627)	4/10/1999 11:36:00 PM
From: Montana Wildhack	Read Replies (1) \| Respond to of 14101

That is very different from what he told my partner who has spoken to him many times. I'll follow up.

To: the Chief who wrote (1627)	4/15/1999 10:28:00 PM
From: Montana Wildhack	Respond to of 14101

Hi Chief, "the answer I got from Peter was that over 2500 people are paying for and using Pennsaid right now. So your understanding, or his statement of 2500+ is wrong?" I don't disagree with you. My question last week was how many of the patients using Pennsaid repeated their prescription? I think thats relevant because it means the patient believes Pennsaid is really helping. To me thats a rough indicator of how the larger market will react and most won't be paying out of their own pockets. (ie: Does the patient think it works?) Anyways, I got a response from Renny Ho in IR. Here is part of what he said: "While we do not disclose specific numbers, it is safe to say hundreds of patients have been using PENNSAID(R) Topical Lotion for over 12 months." Mr Ho also pointed out that a significant number of patients are seniors on fixed income. This is in line with what I heard earlier and I see it as very positive. Hundreds of patients have been paying for Pennsaid for over a year. Now lets get it approved so they can continue to get relief under their drug plans. Are you listening HPB?